IP Catalyst

Molecular Code-Breakers: How Generative AI is Rewriting India’s ₹1.5 Lakh Crore Antibiotic Playbook
Molecular Code-Breakers: How Generative AI is Rewriting India’s ₹1.5 Lakh Crore Antibiotic Playbook
National Pulse

Molecular Code-Breakers: How Generative AI is Rewriting India’s ₹1.5 Lakh Crore Antibiotic Playbook

India is pivoting its ₹1.5 lakh crore pharmaceutical engine toward AI-driven drug discovery to defeat global superbugs. By merging Nvidia-powered computing with sovereign data, the nation is moving from generic manufacturing to high-value IP creation.

1 Comment
May 14, 2026
The $1 Trillion Pivot: Maruti’s Mobility Bet and MeitY’s “IP Refinery” Ignite a New Startup Era
The $1 Trillion Pivot: Maruti’s Mobility Bet and MeitY’s “IP Refinery” Ignite a New Startup Era
Startup & Ecosystem

The $1 Trillion Pivot: Maruti’s Mobility Bet and MeitY’s “IP Refinery” Ignite a New Startup Era

India’s startup landscape is shifting from consumer apps to sovereign tech as Maruti Suzuki and MeitY launch massive deep-tech initiatives. Funding has doubled as the nation eyes a $1 trillion AI-driven future, marking the definitive end of the funding winter.

1 Comment
May 13, 2026